Oncology
25 drugs are in development for Solid Tumors.
- Companies
- 22
- Clinical trials
- 76
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Solid Tumors pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(2)
Phase 2(5)
Phase 1(8)
| Drug | Company |
|---|---|
| atrc-101 | Atreca, Inc. (BCEL) |
| CFT1946 | C4 Therapeutics, Inc. (CCCC) |
| fpt155 | FIVE PRIME THERAPEUTICS, INC. (FPRX) |
| gs-1811 | Jounce Therapeutics, Inc. (JNCE) |
| sl-901 | STEMLINE THERAPEUTICS INC (STML) |
| taladegib | Ignyta, Inc. (RXDX) |
| tbs-2025 | TuHURA Biosciences, Inc./NV (HURA) |
| TYRA-430 | Tyra Biosciences, Inc. (TYRA) |
Preclinical(7)
| Drug | Company |
|---|---|
| fpa157 | FIVE PRIME THERAPEUTICS, INC. (FPRX) |
| io170 | IO Biotech, Inc. (IOBTQ) |
| jtx-1484 | Jounce Therapeutics, Inc. (JNCE) |
| jtx-2134 | Jounce Therapeutics, Inc. (JNCE) |
| mdvac | Orgenesis Inc. (ORGS) |
| sgr-3515 | Schrodinger, Inc. (SDGR) |
| thor-707 | Synthorx, Inc. (THOR) |
Phase 1/Phase 2(3)
| Drug | Company |
|---|---|
| mdx2001 | OPKO HEALTH, INC. (OPK) |
| oric-114 | Oric Pharmaceuticals, Inc. (ORIC) |
| slate | Gritstone bio, Inc. (GRTS) |
About this indication
Solid Tumors context
Oncology·MeSH: Pancreatic Neoplasms (D010190)
Narrower concept of MeSH descriptor Pancreatic Neoplasms
Compare drugs
Frequently asked questions
How many drugs are in development for Solid Tumors?
BioSniper tracks 25 drugs in development for Solid Tumors across 22 companies.
How many clinical trials target Solid Tumors?
There are 76 clinical trials targeting Solid Tumors tracked by BioSniper.